Serpax

Quick links to important sections

Serpax

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Serpax

Quick Facts

Property Description
Active ingredient Oxazepam
Form Tablet or Capsule (Oral)
Pharmacological class Benzodiazepine derivative, Anxiolytic
General Purpose Relief of anxiety and tension
Origin Synthetic compound

Serpax: Definition and Pharmacological Class

Serpax is a synthetic, prescription-only medication defined by its sole active ingredient, Oxazepam. This compound belongs to the major pharmacological group known as Benzodiazepine derivatives, which function as Central Nervous System (CNS) depressants. This classification establishes Serpax as a substance intended to exert a calming and tension-reducing effect on the body, a property associated with managing states of heightened arousal.

The classification as a benzodiazepine derivative underscores its identity as an Anxiolytic and a Sedative-hypnotic agent. Its profile is intermediate-acting, and it demonstrates a specific metabolic pathway. Unlike some benzodiazepine predecessors, Oxazepam undergoes a single-step metabolism via glucuronidation, a feature relevant to the drug's processing in patient groups with compromised liver function.


Composition and Therapeutic Purpose

The fundamental composition of Serpax is the pure Oxazepam compound, manufactured with necessary pharmaceutical excipients for its stability in solid form. As a monotherapy, it delivers only this single, focused active ingredient. The primary benefit of this anxiolytic compound is the reduction of physiological signs associated with excessive nerve activity, for example, helping to mitigate overwhelming restlessness or muscle tension.

By inducing a general depression of CNS activity, the drug's therapeutic purpose is to promote a state of tranquility and calmness. This effect helps to mitigate feelings of significant nervousness or tension by decreasing the overall excitability of the brain, thereby addressing the physical manifestations of emotional arousal.


Available Forms and Administration Type

Serpax is manufactured for oral administration, meaning the medicine is intended to be swallowed. The primary dosage form(s) available to patients are solid preparations, typically presented as either a tablet or a capsule. These oral forms are the standard mechanism for delivering Oxazepam systemically into the body, allowing for measured absorption via the gastrointestinal tract.

Regulatory References

  1. Oxazepam - StatPearls (NCBI Bookshelf)
  2. Oxazepam Drug Information (MedlinePlus)

What side effects are possible with Serpax?

Possible Side Effects and Safety Information

Serpax (Oxazepam) is a central nervous system (CNS) depressant, and its safety profile is defined by effects related to this activity, as classified in official regulatory documents.


Common Adverse Reactions and Organ Systems

The most frequently reported adverse effects are typically manifestations of CNS depression and are most pronounced at the start of treatment. These reactions are classified in regulatory documents under Nervous System Disorders and commonly include drowsiness, sedation, dizziness, ataxia (impaired coordination), and fatigue. Less frequent reactions may include confusion, slurred speech, or headache. Paradoxical reactions, such as excitement or agitation, may also occur and are more likely in certain populations.


Serious Safety Considerations

Official labeling documents serious risks, including respiratory depression, coma, and death, particularly when Oxazepam is used alongside other CNS depressants, notably opioids. Seizures are also noted as a risk upon abrupt discontinuation or rapid dose reduction after chronic use. Rare but serious events include blood dyscrasias and severe allergic reactions.


Time-Related and Population-Specific Safety

Dependence and tolerance are key duration-related safety patterns, with the risk increasing with higher doses or longer use. The official safety profile notes that older adults have an increased susceptibility to adverse effects like severe sedation and falls. Furthermore, regulatory warnings specify that use during late pregnancy is associated with risks of Neonatal Abstinence Syndrome and "Floppy Infant Syndrome."

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents describe Oxazepam (Serpax) overdose as an extension of its central nervous system (CNS) depressant effects, emphasizing that immediate medical attention is required for severe manifestations.

Documented Overdose Manifestations

Classification Manifestations Listed in Official Labels
Mild to Moderate Drowsiness, Confusion, Lethargy, Slurred Speech, Ataxia (loss of coordination)
Severe Outcomes Stupor, Coma, Respiratory Depression, Apnea, Hypotension (low blood pressure)

Required Emergency Actions

Seek immediate medical attention or call emergency services (e.g., 911) right away if a severe overdose is suspected. Urgent help is mandated when symptoms include trouble breathing, shallow or stopped breathing, collapse, or being unresponsive (unable to be awakened).

Treatment is officially defined as symptomatic and supportive, focusing on maintaining an airway and continuous monitoring of vital signs until symptoms resolve. Co-ingestion with other CNS depressants, such as alcohol or opioids, significantly increases the risk of life-threatening respiratory compromise and death. The official antidote, Flumazenil, is available but its use is restricted due to risks, including precipitating seizures.

Therapeutic Uses of Serpax

Serpax: Main Uses and Benefits

Serpax (Oxazepam) is relevant in contexts marked by increased discomfort or tension where symptoms create noticeable physiological strain. It is applied to provide short-term symptomatic relief and supports patient comfort during challenging episodes of heightened symptoms, with a utility centered on managing specific symptomatic manifestations.


This medication is commonly used for managing the symptoms of anxiety disorders, providing support when anxiety occurs alongside depression, and for the acute symptomatic control in patients with alcohol withdrawal syndrome. It helps ease intense feelings of apprehension, persistent worry, muscle tension, and pervasive physical restlessness that interfere with daily functioning.

Its supportive role is often noted for easing symptoms related to physical signs of tension. It assists with maintaining functional stability when symptoms create noticeable physiological strain, which characterizes its supportive role during periods of distress. Furthermore, it is applied for symptom moderation in specific patient groups, such as older adults, where it helps manage heightened agitation and irritability. This supports general well-being during symptomatic phases.

Quick Fact: Relevant for managing Apprehension and Tension

Regulatory References

  1. NIH DailyMed Label

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Serpax (Oxazepam)

This section outlines the official population eligibility and non-eligibility rules for Serpax (Oxazepam) as defined in governmental regulatory documents.

Classification Rule (Strictly Label-Based)
Contraindicated Patients with known hypersensitivity to Oxazepam or other benzodiazepines.
Individuals with severe respiratory depression, acute pulmonary insufficiency, or myasthenia gravis.
Patients with chronic psychosis or phobic/obsessional states (not indicated).
Not Established / Not Recommended Children younger than 6 years of age (safety and efficacy have not been established).
Breastfeeding women (not recommended due to excretion into breast milk).
Pregnant individuals, especially during the first and third trimesters (risk of neonatal withdrawal/sedation).
Conditional / Caution Older adults require lower initial doses due to increased sensitivity and risk of oversedation.
Patients with a history of drug or alcohol abuse/dependence require careful surveillance due to dependence risk.
Caution is advised for patients with kidney or liver disease, though Oxazepam's metabolism may pose less risk than some other benzodiazepines.

Connection to the official eligibility profile: Regulatory documents strictly define who can and cannot use Serpax by establishing absolute contraindications for populations with conditions like severe respiratory impairment or drug hypersensitivity. Eligibility is also restricted by age, as use is not established for young children, and by physiological status, with strong warnings against use during pregnancy and lactation. The official profile permits use primarily in adults who do not possess these specified contraindications or high-risk conditional factors.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Serpax (Oxazepam) is defined by two primary regulatory domains: the enhancement of Central Nervous System (CNS) depression and pharmacokinetic modification of drug exposure. The most significant regulatory caution addresses the combined use of Oxazepam with other depressant substances.

  • Opioids and CNS Depressants: Co-administration with Opioids carries a serious, officially documented risk of profound sedation, respiratory depression, coma, and death due to additive CNS depressant effects. This combination must be reserved for specific cases, requiring the lowest effective dosages and minimum durations. This additive risk also extends to Alcohol and other CNS depressant drugs, including antipsychotics, certain antidepressants, and sedative antihistamines.
  • Exposure Modification: Other medicinal products may alter Oxazepam's concentration. Concurrent use with Oral Contraceptives (oestrogen-containing) or the anti-epileptic Phenytoin may cause oxazepam plasma levels to fall. Conversely, agents such as Probenecid may potentially increase Oxazepam effects by affecting its clearance.
  • Population Notes: Regulatory information notes that Elderly Patients face an increased risk of interaction-related side effects, such as sedation and dizziness, which can lead to falls.

Mechanism of Action

Molecular Mechanism: RANKL Inhibition

Serpax functions as an inhibitor of the osteoclast differentiation pathway. It is a monoclonal antibody that selectively targets and binds to the RANKL-receptor complex on the surface of pre-osteoclasts and mature osteoclasts. This binding event prevents the activation of the receptor by endogenous RANKL.

The resulting molecular blockade inhibits the signaling cascade necessary for osteoclastogenesis (the formation of new osteoclasts) and accelerates the programmed cell death, or apoptosis, of existing osteoclasts. This action effectively reduces the total population and activity of bone-resorbing cells.


Physiological Consequence

The fundamental cellular effect is a decrease in the rate of bone resorption by the suppressed osteoclasts. This modification to the bone remodeling cycle results in a measurable shift in the physiological balance of bone turnover toward net bone formation.

Dosage and Administration Information

How Serpax is Used: Official Administration Guidelines

The official administration guidelines for Serpax (Oxazepam) establish the required procedural structure for its use, strictly defining dosage, frequency, and duration limits.

Parameter Instruction
Route of Administration Oral administration only (intended to be swallowed)
Dosing Frequency 3 or 4 times daily (TID or QID) for anxiety and alcohol withdrawal
Timing in relation to meals Without regard to meals
Available Strengths 10 mg, 15 mg, and 30 mg (Capsule and Tablet forms)

Labeled Dosing and Procedural Constraints

The standard adult dosing for mild-to-moderate anxiety is 10 mg to 15 mg per dose, while severe conditions may require 15 mg to 30 mg per dose. For older adults, initial administration begins at the lower end of the range, typically 10 mg three times daily, which may be cautiously adjusted.

A central condition of use is the limited duration of treatment. Serpax is intended for short-term relief only; its usage is generally restricted, with efficacy not systematically evaluated beyond four months. Clinical guidelines often indicate treatment should not exceed 2 to 4 weeks. The required procedural instruction for concluding treatment is to gradually taper the dosage schedule, never stopping the medicine abruptly. This mandatory tapering ensures a procedurally managed withdrawal from the medication.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Serpax (Oxazepam)


Evidence Supporting Use for Short-Term Anxiety and Tension Relief

Research exploring the use of Serpax in studies of anxiety and tension symptoms primarily relies on short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies are conducted to compare symptomatic outcomes for people using the medicine against those using a placebo (an inactive substance) or another agent. In these trials, researchers primarily monitored changes measured during the study period using standardized instruments, such as the Hamilton Anxiety Rating Scale (HAM-A), which track symptom intensity or variability. Studies reported measurements of change in anxiety symptom scores, providing insight into short-term changes and describing patterns observed in the adult populations studied.

What remains uncertain is how the compound was observed over extended periods. Follow-up durations were limited, with most systematic clinical studies not assessing outcomes beyond approximately four months. There is limited information for long-term outcomes, meaning that the research provides context but not individual predictions about sustained symptomatic change over many months or years.


Research on Exploring Outcomes in Acute Alcohol Withdrawal Symptoms

Serpax was studied for its use in contexts associated with acute or disruptive episodes, specifically exploring outcomes related to the symptoms of alcohol withdrawal syndrome. The evidence structure includes Controlled Clinical Trials which compared the compound to other agents. Studies monitored outcomes linked to physiological strain, such as the severity of withdrawal using clinical scales (e.g., CIWA-Ar). Research has explored the use of this compound in patients with certain co-occurring conditions, and studies have examined populations, such as those with compromised liver function, where the compound's specific metabolic profile was a factor in study design. Comparative evidence against all other specific alternatives for general withdrawal management is lacking.


Evidence in Special Patient Populations

Research has explored the use of this compound in specific groups, notably the older adult (geriatric) population. Studies examined outcomes related to physical discomfort, such as heightened agitation and tension. Studies reported measurements of change in agitation and global symptom scores. However, evidence quality varies across studies, and findings describing group patterns, not personal outcomes, often depend on research derived from the broader benzodiazepine class in this sensitive demographic.

Key Studies & References

  1. Oxazepam: NIH DailyMed Label (Used for indications and populations)
  2. Oxazepam: StatPearls Overview (Used for pharmacological class and metabolic pathway context in special populations)
  3. Summary Public Assessment Report (sPAR) - Delipam (Oxazepam) tablet - Swedish/EU Regulator Document

Frequently Asked Questions (FAQ)

Common questions about Serpax (FAQ)


Q: Is Serpax the same kind of medicine as other similar drugs I've heard of?

According to the official product information, Serpax (Oxazepam) is classified as a benzodiazepine derivative. This designation means it belongs to a group of medicines that share a similar chemical structure and function by acting as central nervous system depressants. This pharmacological class includes many other compounds often discussed in similar contexts.


Q: What are the most common things people misunderstand about how to use Serpax?

Regulatory documents emphasize the importance of using Serpax for short-term relief only, typically restricted to a few weeks or months. A common area for clarification is the need for a gradual dosage reduction when treatment is concluded. Official instructions stress that stopping the medicine abruptly is not recommended due to the potential for withdrawal reactions.


Q: Is it common to feel tired or dizzy when first starting Serpax?

Drowsiness, sedation, and dizziness are among the most frequently reported adverse effects in the official prescribing information. These effects are often noted as being most pronounced at the start of treatment while the body adjusts to the medicine. It is a common expectation that these initial symptoms may be noticeable.


Q: Is it common for side effects from Serpax to go away over time?

Official labeling notes that common effects like sedation are often most pronounced when first starting the medication. However, regulatory information also highlights that time-related safety patterns, such as the development of tolerance and dependence, are documented with continued or long-term use.


Q: What happens if I forget to take a dose of Serpax?

Official patient information describes a procedure where the missed dose is typically taken as soon as remembered, unless it is nearly time for the next scheduled dose. In that case, the missed dose is usually skipped, and the regular schedule is resumed.


Q: How quickly does Serpax typically start to work after the first use?

Serpax is described in pharmacological texts as having a slow onset of action compared to some other medicines in its class. This means the full effect is not immediate. Peak concentrations in the blood, where the maximum effect is typically felt, are generally reported to occur 2 to 4 hours after the medicine is swallowed.


Q: How long does one dose of Serpax usually last in the body?

Serpax is classified as an intermediate-acting medication. Pharmacological texts describe its elimination half-life, which is the time it takes for half of the dose to leave the body, as ranging between approximately 5 to 21 hours. This fact informs its scheduled dosing frequency.


Q: Is it possible to take Serpax 'as needed'?

Official labeling establishes a routine dosing frequency, such as three or four times daily, for the short-term relief of anxiety symptoms. The regulatory information does not typically specify or support a non-scheduled 'as needed' use.


Q: Can Serpax be taken by people who are generally healthy?

Serpax is a prescription-only medication. It is officially indicated for the management of anxiety disorders and the relief of anxiety symptoms. It is not intended for use by people who are generally healthy or who do not have a defined medical indication.


Q: Are there certain common foods or drinks that should be avoided with Serpax?

Official administration instructions state that the medicine can generally be taken with or without food. While there are specific warnings regarding alcohol, regulatory texts do not list any common foods that are strictly forbidden during treatment.


Q: Is it true that Serpax might cause changes in mood or personality?

The official safety profile notes the potential for paradoxical reactions in some individuals. These reactions may include unexpected effects like increased excitement, agitation, or acute rage. Furthermore, changes in mental state or mood are listed among the possible adverse effects.


Q: Are there any known issues with taking herbal supplements with Serpax?

Official drug interaction information specifies caution with certain herbal supplements. Regulatory texts note that combining the medicine with St. John's Wort may cause an increased risk of certain side effects.


Q: Does Serpax show up on standard drug tests?

The active ingredient, Oxazepam, and its metabolite (oxazepam-glucuronide) can be detected in biological fluids, such such as urine and oral fluid following ingestion. The presence of the compound may be relevant during drug testing analysis.


Q: What does official research say about the long-term effects of Serpax?

Official regulatory documents indicate that the efficacy and effectiveness of Serpax were not systematically evaluated beyond four months in the pivotal clinical trials. Therefore, official research provides limited insight regarding the drug's sustained effects over extended periods.


Q: Does Serpax affect sleep patterns, like causing insomnia or oversleeping?

The medication is a central nervous system depressant and is sometimes indicated for anxiety associated with sleeplessness. Common adverse reactions include drowsiness and sedation. However, official documents also list sleep disturbances, including insomnia, as a potential adverse effect.


Q: Is it necessary to have regular blood tests while using Serpax?

Official patient information describes that the medication may affect the accuracy of some laboratory tests. Therefore, it is noted that a healthcare provider should be informed about all medicines being taken before blood tests.


Q: What is the difference between Serpax and a placebo in clinical trials?

Clinical studies that compared Serpax to a placebo (an inactive substance) in the treatment of anxiety have reported some key differences. Patients receiving Oxazepam showed greater improvement in self-evaluated anxiety scores and were more likely to remain on the study than those receiving the placebo.


Q: If I don't feel any changes, does that mean Serpax isn't working for me?

Since Serpax has a slow onset of action, its effects may not be immediately noticeable after the first administration. Pharmacological texts state that peak concentrations are not reached for a few hours. This characteristic is a factual description of the compound's effect profile.


Q: Is Serpax safe to use during pregnancy, according to official guidelines?

Official guidelines state that use during pregnancy is not recommended, particularly during the first and third trimesters. This position is due to documentation of risks of fetal harm and the potential for neonatal withdrawal syndrome if the medication is used near delivery.


Q: Are there any specific safety warnings for children or teenagers using Serpax?

Serpax is not approved for children under 6 years of age in official documents. For individuals under the age of 18, official information notes that the efficacy and safety of the medicine are generally insufficiently established and require a careful medical assessment.


Q: Does the time of day I take Serpax matter?

The official dosing schedule often specifies taking the medicine multiple times a day. Regulatory documents emphasize the importance of taking doses regularly throughout the day to maintain consistent levels in the body. Beyond that regularity, the instructions do not specify a mandatory time of day (e.g., morning versus night).


Q: What is the relevance of the 'Black Box Warning' (if any) associated with Serpax?

Serpax is included in the FDA Boxed Warning, which is a significant safety communication. This warning details the serious risks of co-administration with opioids, as well as the risks of abuse, misuse, addiction, dependence, and withdrawal reactions.


Q: Why do official documents emphasize a slow adjustment when starting Serpax?

Official dosing instructions often include initiating therapy at the lowest effective dosage and increasing it gradually. This slow adjustment is emphasized, particularly in older adults, to manage the risk of common adverse effects, such as over-sedation.


Q: Can Serpax be crushed or split if a patient has trouble swallowing pills?

Official patient information generally includes instructions that the medicine should be swallowed whole with water. The tablets are typically not recommended to be broken, crushed, or chewed to ensure the medicine is delivered as designed.

How should Serpax be stored and disposed of?

How to Store and Dispose of Serpax?

Serpax (oxazepam) is a federal controlled substance (C-IV) that requires specific storage and disposal protocols as defined by official labeling.

Storage Requirement Official Guidance
Temperature Store at controlled room temperature (68 F to 77 F or 20 C to 25 C).
Protection Keep in the original, tightly closed container. Protect from light, moisture, and excess heat. Do not freeze.
Security Store in a safe, secure location, out of sight and reach of children and others, to prevent misuse or theft.

To dispose of unused or expired Serpax, do not flush the medication down a toilet or pour it down a drain. Consult a healthcare provider or pharmacist for guidance on authorized drug take-back programs. If a take-back program is unavailable, follow documented instructions for mixing the medicine with an unappealing substance, placing it in a sealed bag or container, and discarding it with household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Serpax found in:

A-Z Index: